Sign inJoin waitlistJoin the waitlist

Norman Lacayo

Director, Pediatric Oncology Experimental Therapeutics Investigators' Consortium [POETIC] · Stanford Health Care

Credentials: · ·

History

Stanford University Medical Center (1995) CA
1992–1995
Pediatrics
UCSF Medical Center
1987–1990

Research

Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types
PLoS ONE · 2012 · 2,033 citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Cell · 2020 · 1,025 citations
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
The Lancet Oncology · 2010 · 467 citations

Gary Dahl
20 papers
Kathleen Sakamoto
19 papers
Branimir Sikic
13 papers
JR
Jeffrey Rubnitz
11 papers
Kara Davis
11 papers · 6 as a fellow
Ching-Hon Pui
10 papers
Hiroto Inaba
10 papers
YR
Yaddanapudi Ravindranath
9 papers
Jeffrey Taub
7 papers
Raul Ribeiro
7 papers
RA
Robert Arceci
6 papers
Barbara Degar
5 papers

Clinical trials

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Principal investigator · Recruiting · Phase 1
Norman J. Lacayo
2023–2027
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia
Principal investigator · Completed
Children's Oncology Group
2012
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia
Principal investigator · Completed
Children's Oncology Group
2011–2016
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
Principal investigator · Completed
Children's Oncology Group
2011